簡介:SHORTCOMMUNICATIONMOLECULARANDCLINICALDIFFERENCESBETWEENADENOCARCINOMASOFTHEESOPHAGUSANDOFTHEGASTRICCARDIAPHILIPPETANIERE,GHISLAINEMARTELPLANCHE,DANIELAMAURICI,CATHERINELOMBARDBOHAS,?JEANYVESSCOAZEC,?RUGGEROMONTESANO,FRANC?OISEBERGER,?ANDPIERREHAINAUTFROMTHEINTERNATIONALAGENCYFORRESEARCHONCANCERTHEFE′DE′RATIONDESSPE′CIALITE′SDIGESTIVES?ANDTHELABORATOIRED’ANATOMIEPATHOLOGIQUE,?HO?PITALEDOUARDHERRIOT,LYON,FRANCEADENOCARCINOMAOFTHEESOPHAGUSADCEWITHBARRETT’SMUCOSAANDADENOCARCINOMAOFTHECARDIAADCCAREOFTENREPORTEDASASINGLEPATHOLOGICALENTITYINTHISSTUDYWEHAVEUSEDSTRICTANATOMICALPATHOLOGICALCRITERIATODISTINGUISHBETWEENTHESETWOLESIONSANDWEHAVEINVESTIGATEDTHEIRDIFFERENCESINTP53MUTATIONS,MDM2GENEAMPLIFICATION,ANDCYTOKERATINEXPRESSIONDNAWASEXTRACTEDFROMTHETUMORAREASOFFORMALINFIXED,PARAFFINEMBEDDEDSECTIONSIN26ADCCAND28ADCEPATIENTSTP53MUTATIONSWEREDETECTEDBYTEMPORALTEMPERATUREGRADIENTELECTROPHORESISANDIDENTIFIEDBYSEQUENCINGMDM2AMPLIFICATIONWASASSESSEDBYDIFFERENTIALPOLYMERASECHAINREACTIONTHEEXPRESSIONOFCYTOKERATINS4,7,AND13WASEXAMINEDBYIMMUNOHISTOCHEMISTRYINADCC,THEMALETOFEMALERATIOWAS181,COMPAREDTO271INADCEFIVEADCCPATIENTSHADAHISTORYOFOTHERNEOPLASMS,COMPAREDTOONLYONEADCEPATIENTTHETWOTYPESOFTUMORDIFFEREDINTHEPREVALENCEOFTP53MUTATIONS31INADCCAND50INADCEANDOFMDM2GENEAMPLIFICATION19INADCCAND4INADCE,ANDINTHEPATTERNOFEXPRESSIONOFCYTOKERATIN7POSITIVEIN100OFADCEANDIN41OFADCCANDCYTOKERATIN13POSITIVEIN81OFADCEANDIN365OFADCCADCEANDADCCDIFFERINTHEIRCLINICALCHARACTERISTICS,INTHEPREVALENCEOFTP53MUTATIONSANDMDM2AMPLIFICATIONS,ANDINTHEPATTERNSOFCYTOKERATINEXPRESSIONTHESERESULTSSUPPORTTHENOTIONTHATADCCANDADCEAREDISTINCTPATHOLOGICALENTITIESAMJPATHOL2001,15833–40THROUGHOUTTHEPAST20YEARS,THEINCIDENCEOFTUMORSOFTHEESOPHAGOGASTRICJUNCTIONHASINCREASEDATARATEOF5TO10PERYEARINTHEUNITEDSTATESANDSEVERALWESTERNEUROPEANCOUNTRIES1THEREASONSFORTHISINCREASEAREPRIMARILYUNKNOWNTUMORSOFTHEESOPHAGOGASTRICJUNCTIONINCLUDETWOMAJORTYPESOFADENOCARCINOMAADENOCARCINOMASOFTHEESOPHAGUSADCEANDADENOCARCINOMASOFTHECARDIAADCCADCEOCCURINTHEDISTALPARTOFTHEESOPHAGUSANDDEVELOPFROMBARRETT’SMUCOSA,AGLANDULARMETAPLASIAOFTHESQUAMOUSEPITHELIUMTHATCANVARYINHEIGHTFROMAFEWMILLIMETERSTOAFEWCENTIMETERSTHEREISEVIDENCETHATTHEMETAPLASTICGLANDULARCELLSAREHYBRIDCELLS,EXPRESSINGCYTOKERATINSCKSOFBOTHSQUAMOUSCK4AND13ANDGLANDULARCK8AND19ORIGIN2ANDHAVINGULTRASTRUCTURALFEATURESOFBOTHSQUAMOUSANDGLANDULARCELLS3FURTHERMORE,THEYHAVEBEENSHOWNTOCONSTANTLYEXPRESSCK7,INCONTRASTTOINTESTINALMETAPLASTICCELLSOFTHECARDIAMUCOSA,WHICHNEVERDO4BARRETT’SMUCOSAISOFTENASSOCIATEDWITHCHRONICGASTROESOPHAGEALACIDREFLUXHOWEVER,ITCANALSOOCCURINCOMBINATIONWITHCHRONICBILIARYALKALINEREFLUXASWELLASINTHEABSENCEOFREFLUX5FACTORSPREDISPOSINGTOBARRETT’SMUCOSAARENOTWELLDOCUMENTEDRECENTEVIDENCESUGGESTSTHATEXPRESSIONOFCERTAINPOLYMORPHICFORMSOFGLUTATHIONESTRANSFERASEP1MAYBEAGENETICSUSCEPTIBILITYFACTORFORDEVELOPINGBARRETT’SMUCOSA6BARRETT’SMUCOSAISAVERYCOMMONLESIONTHATISTHOUGHTTOOCCURIN?10OFTHEGENERALPOPULATIONINTHEUNITEDSTATESANDISASSOCIATEDWITHA10FOLDINCREASEINTHERISKOFDEVELOPINGADCE7THECARDIAISTHEANATOMICALREGIONCORRESPONDINGTOTHETRANSITIONBETWEENESOPHAGUSANDSTOMACHITCANNOTBEIDENTIFIEDATTHEMACROSCOPICLEVELATTHEMICROSCOPICLEVEL,THECARDIAISCHARACTERIZEDBYATHINMUCOSAWITHCLEARGLANDULARCELLS,WITHOUTANYACIDSECRETINGCELLSITRANGESINHEIGHTFROM1TO5MM,WITHANINCREASEINSIZEWITHAGETHETERM“ADCC”APPLIESTOTUMORSLOCATEDACCEPTEDFORPUBLICATIONSEPTEMBER14,2000ADDRESSREPRINTREQUESTSTOPHAINAUT,PHD,GROUPOFMOLECULARCARCINOGENESIS,IARC,150COURSALBERTTHOMAS,69372LYONCEDEX08,FRANCEEMAILHAINAUTIARCFRAMERICANJOURNALOFPATHOLOGY,VOL158,NO1,JANUARY2001COPYRIGHT?AMERICANSOCIETYFORINVESTIGATIVEPATHOLOGY33ANTIBODY,CLONEAE1/AE3,1/100DAKO,COPENHAGEN,DENMARK,ANDCK13MONOCLONALANTIBODY,CLONEKS1A3,1/50NOVOCASTRALABORATORIESLTDINCUBATIONWITHTHERELEVANTSECONDARYANTIBODIESEITHERANTIMOUSEORANANTIRABBITBIOTINYLATEDIGG,1/200,VECTASTAINELITEABCKITVECTORLABORATORIESINCFOR30MINUTESATROOMTEMPERATUREWASFOLLOWEDBYSTREPTAVIDINPEROXIDASE1/50,30MINUTESAT37°CPEROXIDASEACTIVITYWASDETECTEDWITHADIAMINOBENZIDINEBASEDDETECTIONKITVECTORLABORATORIES,INCANDSECTIONSWERECOUNTERSTAINEDWITHMAYER’SHEMATOXYLINBEFOREDEHYDRATIONANDMOUNTINGTP53MUTATIONANALYSISTP53EXONS4TO9WEREANALYZEDBYTEMPORALTEMPERATUREGRADIENTELECTROPHORESISUSINGTHEDGENESYSTEMBIORAD,RICHMOND,CAANDTHEPRIMERSDESCRIBEDBYHAMELINANDCOLLEAGUES20EXONS5,7,AND8ANDGULDBERGANDCOLLEAGUES21EXONS4,6,AND9DNAWASAMPLIFIEDINADNATHERMOCYCLERPERKINELMER,NORWALK,CTINA50?LREACTIONMIXTURECONTAINING5?LOFGENOMICDNA,20PMOLOFSENSEANDANTISENSEPRIMERS,200?MOL/LOFEACHDNTP,1?AMPLIFICATIONBUFFER,1XQSOLUTIONAND05?L25UOFTAQPOLYMERASEHOTSTARTAQDNAPOLYMERASEQIAGEN,HILDEN,GERMANYPOLYMERASECHAINREACTIONPCRCONDITIONSWERE15MINUTESAT95°CFOLLOWEDBY35CYCLESAT95°C1MINUTE,56°CEXONS5PROXIMAL,8,AND9OR62°CEXONS4A,4B,5DISTAL,6,AND71MINUTE,72°C90SECONDSTHEREACTIONWASENDEDBYA10MINUTESEXTENSIONAT72°CHETERODUPLEXFORMATIONWASINDUCEDBYDENATURATIONFOR10MINUTESAT98°C,FOLLOWEDBY30MINUTESATTHERESPECTIVEANNEALINGTEMPERATURE56°COR62°CTEMPORALTEMPERATUREGRADIENTELECTROPHORESISWASRUNAT130VATTEMPERATURESOPTIMIZEDFOREACHDNAFRAGMENTEXON4P,4D,6,AND958TO70°CEXON5P56TO70°CEXON5D63TO70°CEXON759TO70°CEXON853TO67°CANEGATIVECONTROLWILDTYPESAMPLEANDPOSITIVECONTROLKNOWNMUTANTWEREINCLUDEDINEACHANALYSISSAMPLESTHATSHOWEDADDITIONALAND/ORABNORMALBANDSWEREREAMPLIFIEDFROMGENOMICDNAANDASECONDTEMPORALTEMPERATUREGRADIENTELECTROPHORESISWASPERFORMEDIFCONFIRMED,MUTANTALLELESWERECUTFROMTHISSECONDGEL,REAMPLIFIEDUSINGTHESAMEPRIMERS,ANDANALYZEDBYDIRECTSEQUENCINGAFTERASYMMETRICPCRAMPLIFICATIONSASPREVIOUSLYDESCRIBED20,22TWOCASESWITHPOSITIVEP53IMMUNOSTAINING?50DIDNOTSHOWREPRODUCIBLEPATTERNSOFABNORMALBANDSINTEMPORALTEMPERATUREGRADIENTELECTROPHORESISCASE12,TABLE1,ANDCASE3,TABLE2INTHESETWOCASES,MRNAWASISOLATEDFROMFROZENBIOPSIES,ANDCDNAWASPREPAREDANDTESTEDUSINGTHEYEASTFUNCTIONALASSAYASDESCRIBEDBYFLAMANETAL23POSITIVECOLONIESWERESEQUENCEDUSINGTHEABIPRISM310GENETICANALYZERPERKINELMERBIOSYSTEMS,FOSTERCITY,CAANALYSISOFMDM2GENEAMPLIFICATIONDIFFERENTIALPCRWASPERFORMEDASPREVIOUSLYDESCRIBED24WITHTHEFOLLOWINGMODIFICATIONS5?LOFTEMPLATEDNAWASAMPLIFIEDIN50?LOFAREACTIONMIXTURECONTAINING20PMOLEACHOFSENSEANDANTISENSEPRIMERSFORMDM2ANDFORTHEDOPAMINED2RECEPTORGENEDRD2USEDASAREFERENCE,200?MOL/LOFEACHDNTP,1?AMPLIFICATIONBUFFER,1XQSOLUTIONAND05?L25UOFHOTSTARTAQDNAPOLYMERASEQIAGENPCRCONDITIONSWERE15MINUTESAT95°C,FOLLOWEDBY27CYCLESAT95°CFOR45SECONDS,55°CFOR45SECONDS,AND72°CFOR1MINUTEWITHAFINALEXTENSIONAT72°CFOR5MINUTESTHEPRIMERSWEREASFOLLOWS5?GAGGGCTTTGATGTTCCTGA3?SENSEAND5?GCTACTAGAAGTTGATGGC3?ANTISENSEFORMDM2,AND5?CCACTGAATCTGTCCTGGTATG3?SENSEAND5?GTGTGGCATAGTAGTTGTAGTGG3?ANTISENSEFORHUMANDRD2PCRPRODUCTSWEREELECTROPHORESEDON75POLYACRYLAMIDEGELSSTAINEDWITHETHIDIUMBROMIDE,PHOTOGRAPHED,ANDTHEFILMSWEREANALYZEDBYSCANNINGDENSITOMETRYGS670BIORAD,HERCULES,CAANMDM2/DRD2RATIOOF25ORABOVEWASREGARDEDASINDICATIVEOFMDM2AMPLIFICATIONANDARATIOBETWEEN2AND25WASREGARDEDASCOMPATIBLEWITHMDM2AMPLIFICATIONSTATISTICALEVALUATIONSFREQUENCYTABLESOFINDEPENDENTVARIABLESWEREEVALUATEDFORSTATISTICALSIGNIFICANCEBYPEARSON’SCHISQUARETESTRESULTSCLINICALANDINDIVIDUALCHARACTERISTICSOFTHEPATIENTSTWENTYSIXCASESOFADCCAND28CASESOFADCEWERECOLLECTEDBETWEEN1995AND1999TABLES1AND2INONECASE,ATUMORWASCLASSIFIEDASADCEONTHEBASISOFTHEPREVIOUSDIAGNOSISONBIOPSYOFABARRETT’SMUCOSATHATWASNOLONGERDETECTABLEATSURGERYNONEOFTHEPATIENTSHADRECEIVEDCHEMOTHERAPYORRADIOTHERAPYBEFOREBIOPSYORSURGERYTHEMEANAGEOFPATIENTSWAS621?136YEARSRANGE,25TO82YEARSFORADCCAND681?9YEARSRANGE,50TO82YEARSFORADCETHEGROUPOFADCCPATIENTSINVESTIGATEDINCLUDED17MENANDNINEWOMENMALE/FEMALERATIOOF065,WHEREASTHEADCEPATIENTSWEREALMOSTEXCLUSIVELYMALES27MALESANDONEFEMALEMALE/FEMALERATIO097DESPITETHESHORTFOLLOWUPPERIODFORSOMEOFTHEPATIENTS,MEDICALRECORDSREVEALEDTHATFIVEOFTHEADCCPATIENTSHADADDITIONALTUMORSTHREEWOMENDEVELOPEDABREASTADENOCARCINOMAEITHERBEFORE19YEARS,PATIENT422YEARS,PATIENT46ORAFTER3YEARS,PATIENT33DIAGNOSISOFADCCONEOFTHESEPATIENTSPATIENT46ALSODEVELOPEDAMALIGNANTMELANOMA10YEARSBEFOREADCCONEMANPATIENT38HADANADENOCARCINOMAOFTHEINTESTINE10YEARSBEFOREADCCANDANOTHERPATIENT29PRESENTEDAPLEOMORPHICADENOMAOFTHEPAROTID5YEARSBEFOREADCCAMONGTHEADCEPATIENTS,ONLYONEPATIENTHADAHISTORYOFAPREVIOUSCANCERASQUAMOUSCELLCARCINOMAOFHEADANDNECKINAMALEPATIENTWHOWASAHEAVYSMOKERANDESOPHAGEALANDGASTRICCARDIAADENOCARCINOMAS35AJPJANUARY2001,VOL158,NO1
下載積分: 10 賞幣
上傳時(shí)間:2024-03-13
頁數(shù): 8
大?。?0.26(MB)
子文件數(shù):